Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
ClinicalTrials.gov study NCT04392154. IPD Sharing: YES. Countries: 16. Publications: 2.
The Inner Garden and Care for Children With Moderate to Severe Agitation
ClinicalTrials.gov study NCT04610281. IPD Sharing: YES. Countries: 1. Publications: 9.
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.
ClinicalTrials.gov study NCT02698436. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03559270. IPD Sharing: YES. Countries: 3. Publications: 2.
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
ClinicalTrials.gov study NCT03607422. IPD Sharing: YES. Countries: 23. Publications: 14.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT01458951. IPD Sharing: Not stated. Countries: 29. Publications: 36.
Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT02114931. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
ClinicalTrials.gov study NCT01922895. IPD Sharing: NO. Countries: 1. Publications: 2.
Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE)
ClinicalTrials.gov study NCT07161960. IPD Sharing: NO. Countries: 1. Publications: 6.
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04178967. IPD Sharing: YES. Countries: 8. Publications: 11.
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
ClinicalTrials.gov study NCT01508936. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
ClinicalTrials.gov study NCT02618187. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects
ClinicalTrials.gov study NCT02536833. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
ClinicalTrials.gov study NCT01393626. IPD Sharing: Not stated. Countries: 18. Publications: 1.
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause
ClinicalTrials.gov study NCT04003155. IPD Sharing: YES. Countries: 7. Publications: 8.
NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00936585. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT03276078. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
ClinicalTrials.gov study NCT01033071. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
ClinicalTrials.gov study NCT03051217. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD
ClinicalTrials.gov study NCT02343458. IPD Sharing: YES. Countries: 11. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.